Adverum Biotechnologies Inc (NASDAQ: ADVM) is 25.93% higher on its value in year-to-date trading and has touched a low of $6.38 and a high of $29.70 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ADVM stock was last observed hovering at around $8.78 in the last trading session, with the day’s gains setting it 0.7%.
Currently trading at $9.48, the stock is 29.17% and 20.35% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing 7.97% at the moment leaves the stock -13.65% off its SMA200. ADVM registered -57.10% loss for a year compared to 6-month loss of 18.44%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 29.51% gain in the last 1 month and extending the period to 3 months gives it a -16.48%, and is 21.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.40% over the week and 8.96% over the month.
Adverum Biotechnologies Inc (ADVM) has around 121 employees, a market worth around $196.80M and $0.00M in sales. Distance from 52-week low is 48.59% and -68.08% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.84%).
Adverum Biotechnologies Inc quarterly earnings per share for the current quarter are estimated at -$1.45 with sales reaching $110k over the same period.The EPS is expected to grow by 49.48% this year, but quarterly earnings will post -90.80% year-over-year.
The shares outstanding are 20.76M, and float is at 13.03M with Short Float at 6.26%.
Adverum Biotechnologies Inc (ADVM) Insider Activity
The most recent transaction is an insider purchase by Leonard Braden Michael, the company’s 10% Owner. SEC filings show that Leonard Braden Michael bought 80,718 shares of the company’s common stock on Jul 18 ’24 at a price of $9.11 per share for a total of $0.74 million. Following the purchase, the insider now owns 2.18 million shares.
Adverum Biotechnologies Inc disclosed in a document filed with the SEC on Jul 17 ’24 that Leonard Braden Michael (10% Owner) bought a total of 135,546 shares of the company’s common stock. The trade occurred on Jul 17 ’24 and was made at $7.75 per share for $1.05 million. Following the transaction, the insider now directly holds 2.1 million shares of the ADVM stock.
Still, SEC filings show that on Feb 07 ’24, Lupher, Jr. Mark L. (Director) acquired 130,000 shares at an average price of $1.35 for $0.18 million. The insider now directly holds 130,000 shares of Adverum Biotechnologies Inc (ADVM).
